Investigation of Orai1 inhibition in HepG2 cells reveals cholesterol pathways remodelling with implications for cardiovascular disease

Aldawsari, A.M. orcid.org/0000-0002-0355-8232, Hemmings, K.E., Yuldasheva, N.Y. orcid.org/0000-0001-6213-6358 et al. (5 more authors) (2026) Investigation of Orai1 inhibition in HepG2 cells reveals cholesterol pathways remodelling with implications for cardiovascular disease. In: Cardiovascular Research. Frontiers in CardioVascular Biomedicine 2026, 17-19 Apr 2026, Leuven, Belgium. Vol. 122 (Supplement_1). Oxford University Press (OUP), i191-i192. ISSN: 0008-6363. EISSN: 1755-3245.

Metadata

Item Type: Conference abstract
Authors/Creators:
Dates:
  • Published (online): 14 May 2026
  • Published: 14 May 2026
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
The University of Leeds > Faculty of Environment (Leeds) > School of Food Science and Nutrition (Leeds)
Date Deposited: 11 Jun 2026 11:23
Last Modified: 11 Jun 2026 11:23
Status: Published
Publisher: Oxford University Press (OUP)
Identification Number: 10.1093/cvr/cvag092.152
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)